Phase 3 SON Clinical Trials
32 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 32 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals300 enrolled2 locationsNCT07498426
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Parkinson's Disease
Hoffmann-La Roche900 enrolled142 locationsNCT07174310
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Parkinsons Disease (PD)
BlueRock Therapeutics102 enrolled39 locationsNCT06944522
Recruiting
Phase 2Phase 3
A Study of Buntanetap in Participants With PD
Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting
Phase 3
A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions
For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions
Shanghai Shengdi Pharmaceutical Co., Ltd250 enrolled2 locationsNCT07275814
Recruiting
Phase 2Phase 3
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)
Remote vs. In-PersonRemote VisitsIn-person Visits
State University of New York at Buffalo200 enrolled2 locationsNCT06822049
Recruiting
Phase 3
A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions
For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)
Shanghai Shengdi Pharmaceutical Co., Ltd306 enrolled2 locationsNCT07275723
Recruiting
Phase 2Phase 3
Effect of Nutritional Ketosis on Alcohol Metabolism
Magnetic Resonance ImagingAlcohol DrinkingKetogenic Dieting+2 more
University of Pennsylvania20 enrolled1 locationNCT06065657
Recruiting
Phase 2Phase 3
Montelukast in Parkinson Disease
Parkinson Disease
Mostafa Bahaa60 enrolled1 locationNCT06113640
Recruiting
Phase 3
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
PARKINSON DISEASE (Disorder)
University Hospital Tuebingen150 enrolled3 locationsNCT07151378
Recruiting
Phase 3
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Parkinson's Disease (PD)Freezing of GaitFreezing of Gait Symptoms in Parkinson Disease
Radboud University Medical Center60 enrolled1 locationNCT07316296
Recruiting
Phase 3
18F-DOPA II - PET Imaging Optimization
Neuroendocrine TumorsBrain TumorNeuroblastoma+3 more
University of Alberta800 enrolled1 locationNCT04706910
Recruiting
Phase 2Phase 3
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Parkinson Disease
Tanta University46 enrolled1 locationNCT06785298
Recruiting
Phase 2Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Parkinson Disease
Biohaven Therapeutics Ltd.550 enrolled15 locationsNCT06976268
Recruiting
Phase 3
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Parkinson Disease
Cerevance330 enrolled49 locationsNCT06553027
Recruiting
Phase 3
Testosterone for Low Sexual Desire in Premenopausal Women: A randomized, double-blind, placebo-controlled trial: The SYBIL study
Low sexual desire with personal distressHypoactive Sexual Desire DisorderLow sexual distress
Womens' Health Research Program, Monash University Public Health and Preventative Medicine260 enrolled1 locationACTRN12625001376437
Recruiting
Phase 2Phase 3
Vinpocetine in Patients With Parkinsonian Disease
Parkinson Disease
Tanta University60 enrolled1 locationNCT07229664
Recruiting
Phase 2Phase 3
Metformin in Parkinson Disease
Parkinson Disease
Tanta University60 enrolled1 locationNCT07229651
Recruiting
Phase 3
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial
Parkinsons Disease (PD)
University College, London1,200 enrolled2 locationsNCT07207057
Recruiting
Phase 3
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Allergic Rhinitis, Seasonal
Genrix (Shanghai) Biopharmaceutical Co., Ltd.150 enrolled1 locationNCT07154342